Inject Solesta: For a significant reduction in fecal incontinence episodes^1,2

Dramatic reductions in fecal incontinence episodes at each time point up to 36 months from baseline^1,2

42.7% reduction in the median number of FI episodes in as little as 3 months¹

53.3% reduction in the median number of FI episodes through 36 months²

All three studies show an increase in number of fecal incontinence-free days²

• ~2X increase of incontinence free days^2,3

• The mean increased number of FI free days at 6 and 12 months was greater in Solesta Treatment vs. SHAM^2,3

• Durable efficacy—dramatic reductions in fecal incontinence episodes at each time point up to 12 months from baseline¹

• Solesta was proven effective for up to 24 months following treatment in the pivotal clinical study and proof-of-concept study¹

Learn more about how Solesta delivers durable efficacy